-
WuXi Giant Nuo BCMA Targeted CAR-T Therapy Applied for Clinical Application
Time of Update: 2021-09-06
Today, the Center for Drug Evaluation (CDE) of the National Medical Products Administration of China announced that WuXi Junuo's JWCAR129 (targeting BCMA chimeric antigen receptor T cell) clinical trial application has been accepted .
Screenshot source: CDE official website
-
Russia notified that an imported Brazilian food was unqualified and temporarily banned its import
Time of Update: 2021-07-31
Food Partner Network News Food Consumers Supervise Imports to Brazil In order to prevent imported products from adversely affecting national health and the spread of large-scale infectious diseases, the Consumer Rights Protection and Public Welfare Supervision Bureau announced that the import of the above-mentioned food will be temporarily banned from July 19, 2021 until further notice .
-
Russia and China hold video negotiations on bilateral import and export of plant products
Time of Update: 2021-07-31
Food Partner Network News China General Administration of Customs Import and Export During the negotiation process, the two parties held consultations on the export of Russian alfalfa to China: Russia had submitted a draft protocol to China in April 2021, and China stated that it is discussing and reviewing relevant documents .
-
Jilin Aodong: Obtained the registration certificate of adenosylmethionine succinate for injection
Time of Update: 2021-07-18
On March 15, Jilin Aodong announced that the holding subsidiary Jilin Aodong Pharmaceutical Group Yanji Co. , Ltd. received the "Adenosylmethionine Succinate for Injection" "Drug Registration Certif
-
Shenzhen: Regulate the administrative examination and approval of hazardous chemicals and precursor chemicals
Time of Update: 2021-07-06
The Shenzhen Municipal Work Safety Supervision Bureau stated that it is applying for the issuance of safety production licenses for hazardous chemicals production enterprises, the issuance of hazardous chemicals safe use licenses, the review of safety conditions for hazardous chemical construction projects, and the production of Class I non-pharmaceutical precursor chemicals.
-
IBD: Higher concentrations of infliximab can improve blood and fecal neutrophil biomarkers in patients with Crohn's disease
Time of Update: 2021-06-29
This study determined the cut-off values of neutrophil fecal and blood biomarkers for the biochemical remission after IFX induction therapy and the trough concentration level of therapeutic drugs, which can provide some help for clinical treatment .
-
Beijing's 350-meter pharmacy limit canceled
Time of Update: 2021-06-22
, The distance to existing pharmacies is no longer a condition for permit review .
It is reported that this is after Shanghai this year, another super first-tier city has cancelled the distance limit for pharmacies .
-
Novo Nordisk's new diabetes drug enters "pending approval", a long-acting GLP-1 analogue once a week
Time of Update: 2021-05-10
If approved successfully, it will bring new treatment options to Chinese patients with type 2 diabetes.
The results showed that after 30 weeks, smeglutide significantly reduced HbA1c by 1.
This shows that simeglutide can be an effective treatment for blood sugar control in patients with type 2 diabetes.
-
The world's new generation of high-dose iron injection Monofi® was launched in China, treating iron deficiency anemia
Time of Update: 2021-05-02
"Monofi® has obvious advantages in blood management after perioperative, especially in the need for rapid, high-dose intravenous iron supplementation, and can improve blood quality before surgery.
-
Green tea extract may regulate the facial development of children with Down syndrome! Low-dose extract may improve its facial development
Time of Update: 2021-04-28
1038/s41598- 021-83757-1 Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome Sci Rep【2】com/news/2021-03-green-tea-supplements-modulate-facial.
-
Osaikang Pharmaceutical's dexrazoxane for injection has been approved
Time of Update: 2021-04-28
On March 17, the official website of the State Administration of Food and Drug Administration showed that Jiangsu Aosaikang Pharmaceutical's dexrazoxane for injection was approved for listing in imitation 3 categories, and it was deemed to have been reviewed.
-
Nestlé recalls two frozen cones containing undeclared allergens
Time of Update: 2021-04-22
html" class="zdbq" title="Canada related food information" target="_blank">Canadian foodmate.
html" class="zdbq" title="Recall related food information" target="_blank">a recall notice, foodmate.
html" class="zdbq" title="Frozen related food information" target="_blank">frozen cone, because the product contains undeclared foodmate.
html" class="zdbq" title="Recall related food information" target="_blank">Recalls foodmate.
-
Vietnam's cassava export market develops well in the first three months of 2021
Time of Update: 2021-04-22
html" class="zdbq" title="Export-related food information" target="_blank"> Domestic cassava prices soared The Import and Export Bureau of the Ministry of Industry and Trade of Vietnam estimated that in March 2021, the national export volume of cassava and cassava products reached 385,000 tons, and the export value reached 142 million US dollars.
-
New Pediatric Drug for Neurogenic Detrusor Hyperactivity (NDO
Time of Update: 2021-04-19
com" target="_blank">/--The Japanese pharmaceutical company Astellas recently announced that the US Food and Drug Administration (FDA) has approved: (1) Myrbetriq tablets (mirabegron, Mirabegron, sustained-release tablets) for treatment Children with neurogenic detrusor hyperactivity (NDO) aged ≥3 years and weighing ≥35 kg; (2) Myrbetriq granules (mirabegron, Mirabegron, oral suspension), used to treat age ≥ A 3-year-old NDO pediatric patient.
-
"Behind the scenes" of repeated abnormal liver function | Case Sharing
Time of Update: 2021-04-18
Serum biochemical indicators: The typical abnormal serum biochemical indicators of AIH are mainly manifested as liver cell injury type changes, increased AST and ALT activities, while ALP and GGT levels are normal or slightly increased; 2.
